Jing Wang
University Medical Center Groningen
4 Papers
5 Citations
Jing Wang is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Mass screening & Breast cancer screening. The author has an hindex of 2, co-authored 4 publications.
Chat about Author
Papers
Is Ultrasound an Accurate Alternative for Mammography in Breast Cancer Screening in an Asian Population? A Meta-Analysis
Jing Wang,Senshuang Zheng,Lanjun Ding,Xuan Liang,Yuan Wang,Marcel J. W. Greuter,Marcel J. W. Greuter,Geertruida H. de Bock,Wenli Lu +8 more
- 21 Nov 2020
TL;DR: In conclusion, based on the currently available data on sensitivity alone, there is no indication that ultrasound can replace mammography in breast cancer screening in Asian women.
26
Mammographic sensitivity as a function of tumor size: A novel estimation based on population-based screening data.
Jing Wang,Pam Gottschal,Lilu Ding,Danielle W. A van Veldhuizen,Wenli Lu,Nehmat Houssami,Marcel J. W. Greuter,Marcel J. W. Greuter,Geertruida H. de Bock +8 more
TL;DR: Derived from aggregated breast screening outcomes data, a model’s estimation of sensitivity as a function of tumor size may provide a better representation of data observed in screening programs than other models.
19
Assessment of the Benefits and Cost-Effectiveness of Population-Based Breast Cancer Screening in Urban China: A Model-Based Analysis
Jing Wang,Marcel J. W. Greuter,Marcel J. W. Greuter,Senshuang Zheng,Danielle W. A van Veldhuizen,Karin M. Vermeulen,Yuan Wang,Wenli Lu,Geertruida H. de Bock +8 more
TL;DR: In this article, the authors assess the effectiveness and cost-effectiveness of implementing biennial mammography screening for women aged 45-70 years in urban China using a micro-simulation model.
7
The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program
Jing Wang,Xuan-Anh Phi,Marcel J. W. Greuter,Alicja M. Daszczuk,Alicja M. Daszczuk,Talitha L Feenstra,Ruud M. Pijnappel,Karin M. Vermeulen,Nico Buls,Nehmat Houssami,Wenli Lu,Geertruida H. de Bock +11 more
TL;DR: DBT has the potential to be cost-effective for screening all women when sensitivity is at least 90% at a maximum cost per screen of €80, and whether DBT could be used as an alternative to mammography for screened all women is highly dependent on the cost of DBT per screen.